Literature DB >> 3319031

Inflammation--histamine and 5-hydroxytryptamine.

D A Owen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319031     DOI: 10.1093/oxfordjournals.bmb.a072181

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  8 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

2.  [Modifying regeneration success of glued nerve anastomosis by local corticoid administration].

Authors:  T Herter
Journal:  Unfallchirurgie       Date:  1990-06

3.  Experimental mast cell activation improves connective tissue repair in the perforated rat mesentery.

Authors:  L Franzén; R Ghassemifar; P Malcherek
Journal:  Agents Actions       Date:  1991-07

4.  Histamine release from basophils in cystic fibrosis.

Authors:  W Schönfeld; A Saak; G Steinkamp; H Van der Hardt; W König
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

5.  Inhibition of hind-paw edema and cutaneous vascular plasma extravasation by 2-chloro-3-methoxycarbonylpropionamido-1,4-naphthoquinone (PP1D1) in mice.

Authors:  J P Wang; Y H Chen; S C Kuo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

6.  Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors.

Authors:  R Burde; R Seifert; A Buschauer; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

7.  Role of histamine in a rat model of colitis.

Authors:  C M Gelbmann; K E Barrett
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

8.  Suppressive effect of 2-phenyl-4-quinolone (YT-1) on hind-paw edema and cutaneous vascular plasma extravasation in mice.

Authors:  J P Wang; M F Hsu; S L Raung; S C Kuo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.